The fate of a $6 billion bankruptcy settlement involvingPurdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in the balance as the U.S. Supreme Court prepares to hear arguments on Monday.

The settlement, which aims to address the devastating opioid epidemic, has been met with mixed reactions, with some praising its potential to provide much-needed relief while others criticize the immunity it grants the Sackler family, Purdue's wealthy owners.

Multi-billion-dollar Agreement At Stake

If approved by the Supreme Court, the settlement would allocate billions of dollars to addiction treatment and other...